Forward P/S Multiple: IceCure Medical Ltd. (ICCM)

IceCure Medical - graphic logo of issuer ICCM

Sales of advanced ProSense systems are driving the current growth of IceCure Medical Ltd (ICCM). The application of minimally invasive cryoablation methods reduces waste, supporting the principles of sustainable healthcare. The forward P/S history demonstrates valuation dynamics, where the value has stabilized at 0.60. However, risks are associated with slow technology adoption by physicians, dependence on insurance reimbursements, and the need for FDA approval.

IceCure Medical - ICCM Market Cap to Projected Revenue (period 07/04/2022 - 11/14/2026)

Summary analytical data breakdowns for icecure-medical.com (ICCM)

- market price and analyst price targets:
Price Chart IceCure Medical|ICCM - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization IceCure Medical Ltd|ICCM - Total Enterprise Value
- issuer book value statistics:
Book Value per Share IceCure Medical|ICCM - Accounting Capitalization|Market Capitalization to Book Value Ratio icecure-medical.com|ICCM - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital IceCure Medical Ltd|ICCM - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital IceCure Medical|ICCM - Company Aggregate Debts|Debt to Book Capitalization Ratio IceCure Medical Ltd|ICCM - Company Long-Term Debt|Company Current Liabilities IceCure Medical|Quick Ratio icecure-medical.com
- financial results and valuation multiples details:
ICCM - Company Net Income|Expected Profit IceCure Medical Ltd|ICCM - Market Cap to Net Income Ratio|Projected Price to Earnings IceCure Medical|ICCM - PEG Multiple|EV/EBITDA Multiple IceCure Medical Ltd|ICCM - Operating income before deduction of amortization|Earnings per share for the last twelve months IceCure Medical|ICCM - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months icecure-medical.com|ICCM - Net earnings per share growth this year|Earnings growth forecast for next year IceCure Medical Ltd
- sales and revenue indicators:
ICCM - Company Total Revenue|Company Projected Revenue IceCure Medical|ICCM - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple IceCure Medical Ltd
Fundamental company analysis:ICCM (IceCure Medical, Ltd.)
Product sample of icecure-medical.com

To protect portfolio capital, priority is given to assets with predictable revenue growth, which for IceCure Medical Ltd (ICCM) is driven by high operating leverage from the sale of disposable cryoprobes. The trend of the future P/S metric reflects the market valuation of expected sales volume relative to market capitalization, allowing investors to determine the extent of future income compression under the influence of inflationary pressure and operating expenses.

Who IceCure Medical Ltd competes with

Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio lensar.com LNSR|Price-to-Projected Revenue Ratio AVITA Medical (RCEL)|profoundmedical.com (PROF) - Projected Price to Revenue|Baird Medical - Forward Price-to-Revenue Multiple|Forward P/S Multiple EDAP TMS SA EDAP|Bovie Medical - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corporation)|Price-to-Projected Revenue Ratio Sensus Healthcare Corp|Forward Price-to-Revenue Multiple Zynex Corp (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Projected Revenue|IRIX: Forward Price-to-Revenue Multiple|Intelligent Bio Solutions - Price to Expected Revenue Ratio|XAIR: Forward P/S Multiple|PFSA - Market Cap to Expected Sales Ratio|SSKN (STRATA Skin Sciences Inc.) - Forward P/S Multiple|Forward Price-to-Revenue Multiple glucotrack.com (GCTK)|Forward P/S Multiple NAOV|VERO - Market Cap to Future Revenue Ratio|Forward P/S Multiple NUWE (Nuwellis, Inc.)|AEMD - Forward Price-to-Revenue Multiple|ASXC: Forward Price-to-Revenue Multiple|AVGR - Forward P/S Multiple|BioSig Technologies, Inc (BSGM) - Price-to-Projected Revenue Ratio|Cutera Inc - Forward Price to Sales|KNW (Know Labs, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio inarimedical.com NARI|Forward Price-to-Revenue Multiple NVRO (Nevro)|RSLS (reshapelifesciences.com) - Forward Price to Sales|Price-to-Projected Revenue Ratio Silk Road Medical Inc. SILK